Fenix Entertainment
On 12 August 2020, Fenix Entertainment S.p.A. obtained admission to negotiate ordinary shares on AIM Italia, a multilateral negotiations system organized and managed by Borsa Italiana. Negotiations began on 14 August 2020.
Integrae SIM acted as the Nomad of the Issuer.
The admission of Fenix Entertainment took place following the placement in Capital Increase of a total of 377,500 shares, at an offer price of 4 euros per share, for a total equivalent value of 1.51 million euros. The capitalization concerning the offer price is equal to Euro 9.51 million, and Euro 11.3 million at the end of the first day of negotiating.
The enterprise. Fenix Entertainment has started the activity through co-productions of films and musical productions of quality works and artists, winners of awards at the Festivals, and a source of accreditation and strengthening the visibility of the brand. The start of the autonomous production activity took place in 2019, both in the cinema (with “Burraco Fatale”, distributed in 2020), and in TV programs (“That’s Amore”, broadcast in 2019 by Rai3). The distinctive feature of Fenix is its presence throughout the value chain, both in the cinema-television and music sectors: from the choice of subjects to a screenplay, from production, co-production, and post-production, up to distribution.
Ultima Ricerca Fenix Entertainment
BREAKING NEWS| In the press release dated August 7, 2025, Litix SpA, an Innovative SME that combines art, technology, tradition, and innovation through three business units offering solutions ranging from the design and production of robotic cells for marble and other materials, to the creation of sculptures and other artistic and design works, to hardware and software development for additive manufacturing and other advanced processes, announced that its subsidiary Aivox Srl will take part, as an industrial partner, in the national research project “More4Neuro – Multi-material 3D Printing for Education in Neurosurgery.” The initiative, led by the University of Milan within the framework of the Partenariati Estesi – HealthTech program, aims to develop next-generation simulators for medical and neurosurgical training, capable of accurately replicating the tactile, mechanical, and structural properties of brain tissues through multimaterial additive manufacturing technologies. Aivox, specialized in computational design, software development, additive manufacturing, and multimaterial 3D printing, will contribute its expertise by taking responsibility for the design of physical models, definition of production processes, and validation of prototypes through iterative development and clinical testing phases. The activities assigned to Aivox have a total value of € 0.68 million, of which € 0.54 million will be covered by public funding. This project marks another step in the strategy outlined in the latest annual report, in which Litix emphasized the importance of diversifying its portfolio with highly innovative projects and strengthening its position in advanced technology markets, based on the belief that technological development and global presence are the key growth drivers in the medium term. Following a transitional year in 2024, which marked the first full year of Aivox’s operations, the participation in More4Neuro confirms the Group’s ability to seize opportunities in high-potential sectors, expanding the intersection between digital manufacturing and specialized education. Considering the information disclosed in the press release, we confirm our recommendation: Target Price € 2.50, BUY Rating and MEDIUM Risk. |
